News from janssen pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 29, 2010, 12:37 ET

Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities

Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) today announced an agreement with the U.S. Attorney's Office for the District of Massachusetts,...

Dec 10, 2009, 07:57 ET

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection

Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new...

Dec 04, 2009, 07:00 ET

Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment

Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the...

Nov 19, 2009, 14:07 ET

AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season

As the seasons change, another season of coughs and running noses is here. Here's more on preparing yourself. Listen to this report from...

Nov 16, 2009, 08:00 ET

National Expressions of Courage Art Contest Unveils Stories of Inspiration

Epilepsy and seizures affect nearly 3 million Americans of all ages and in 70 percent of new cases, no cause is apparent. Those who live...

Nov 11, 2009, 08:00 ET

Analysis Underscores Financial Burden of Mental Illness On Criminal Justice and Health Care Systems

Results from a large, retrospective analysis of inmates with a serious mental illness (SMI) underscores the financial burden of mental illness on...

Aug 21, 2009, 17:15 ET

FDA Issues Complete Response Letter for Carisbamate

The U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the New Drug Application (NDA) for carisbamate, an...

Aug 03, 2009, 08:09 ET

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

The U.S. Food and Drug Administration approved INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) extended-release injectable suspension for the...

May 18, 2009, 08:00 ET

FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder

RISPERDAL(R) CONSTA(R) is the First and Only Long-Acting Antipsychotic Therapy Available for Bipolar I Disorder Janssen(R), Division of...

Apr 22, 2009, 08:00 ET

Video: Adults 'Facing' ADHD: ADHD Allies(TM) Offers Unique Online Community for Adults with ADHD on New Facebook(R) Page

Although Attention Deficit Hyperactivity Disorder (ADHD) is a condition commonly thought of as only affecting children, for nearly 9 million adults...

Mar 03, 2009, 19:05 ET

AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals: Risks of Overusing Antibiotics

They're one of the 20th century's greatest medical advances, but overuse of antibiotics can have great potential risks as well. Listen to this...

Mar 03, 2009, 09:23 ET

Professional Skin Care Company OrthoNeutrogena Becomes Ortho Dermatologics

- New identity reflects company's complete portfolio of Rx and specialty aesthetic products - Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced...

Dec 31, 2008, 09:00 ET

PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches

Other Strength Patches (12.5, 25, 75 and 100 mcg/hr) Not Affected PriCara(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., said today...

Dec 10, 2008, 08:30 ET

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

Results of Two Trials Identify Potential Initiation Dosing Regimen Paliperidone palmitate, an investigational long-acting therapy (LAT)...

Nov 01, 2008, 17:15 ET

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant...